Tributary Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Sell
252,984
-7,478
-3% -$384K 0.98% 52
2026
Q1
$15.4M Buy
260,462
+36,925
+17% +$2.4M 1.5% 26
2025
Q4
$13.8M Buy
223,537
+33,832
+18% +$2.07M 1.36% 39
2025
Q3
$11.8M Buy
189,705
+42,264
+29% +$2.94M 1.07% 48
2025
Q2
$11.8M Buy
+147,441
New +$12.3M 1.04% 51

Other funds holding PBH

Tributary Capital Management's PBH Position: Q2 2026 in Review

Tributary Capital Management reduced its Prestige Consumer Healthcare (PBH) stake by 2.9% in Q2 2026, selling an estimated $384K and leaving 252,984 shares worth $12M. The position accounts for 0.98% of the portfolio, ranked #52.

Tributary Capital Management first reported a position in PBH in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.4M in Q1 2026. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Tributary Capital Management held 252,984 shares of Prestige Consumer Healthcare worth $12M as of Q2 2026.
  • Tributary Capital Management sold 7,478 Prestige Consumer Healthcare shares in Q2 2026, an estimated $384K.
  • Prestige Consumer Healthcare made up 0.98% of Tributary Capital Management's portfolio in Q2 2026, its #52 holding.
  • Tributary Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 5 quarters since.
  • Tributary Capital Management's Prestige Consumer Healthcare position peaked at $15.4M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Tributary Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.